ACO Antibodies

Santa Cruz Biotechnology features a diverse variety of ACO monoclonal antibodies for studying acyl-CoA oxidase (ACO) proteins in research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Acyl-CoA oxidase plays a crucial role in the metabolism of fatty acids, facilitating the oxidation of acyl-CoA to generate energy and produce hydrogen peroxide as a byproduct. ACO is essential for maintaining lipid homeostasis and has been implicated in various metabolic disorders, making it a significant target for research in metabolic diseases and therapeutic interventions. Understanding the function and regulation of acyl-CoA oxidase is vital for advancing knowledge in cellular metabolism and developing potential treatments. ACO monoclonal antibodies enable precise detection and quantification of acyl-CoA oxidase expression levels across different tissue types and experimental conditions. Researchers can track ACO localization within cells and monitor changes in expression patterns under various physiological and pathological conditions. Advanced imaging techniques combined with ACO monoclonal antibodies allow for detailed visualization of protein distribution and interactions. Santa Cruz Biotechnology monoclonal antibodies for ACO support researchers worldwide in advancing our understanding of metabolic processes and developing new therapeutic strategies.